Skip to content

Registry for Degenerative Spinal Disease (RDSD)

Registry for Degenerative Spinal Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05332249
Acronym
RDSD
Enrollment
5000
Registered
2022-04-18
Start date
2021-03-08
Completion date
2050-12-30
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degeneration Spine, Surgery

Keywords

Spine, Outcomes, Degeneration spine, Surgery

Brief summary

The outcome after spinal surgery is important and the evidence is critical to develop treatment. The purpose of this study is to make a prospective registry of database for further research.

Detailed description

The outcome after spinal surgery is important and the evidence is critical to develop treatment. The purpose of this study is to make a prospective registry of database for further research. Included patients Degenerative cervical spinal disease. Degenerative lumbar spinal disease.

Interventions

PROCEDURESurgery

Patients who undergo spinal surgery for degenerative spinal disease

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years

Inclusion criteria

* Degenerative lumbar spinal disease. * Degenerative Cervical spinal disease

Exclusion criteria

* combined progressive cancer disease

Design outcomes

Primary

MeasureTime frameDescription
Disability index20 yearsImprove of disability index more than 30% from the baseline

Secondary

MeasureTime frameDescription
C7-sagittal vertical axis (C7-SVA)20 yearsChange of C7-SVA, quantative comparison between preoperation and postoperative year 20 years.
European quality of life questionnare _ 5 dimension (EQ-5D)20 yearsImprove of EQ-5D more than 30% from the baseline

Countries

South Korea

Contacts

Primary ContactChi Heon Kim, Pf.
chiheon1@snu.ac.kr+82-2-2072-2358

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026